Last updated: September 5, 2023
Sponsor: Bluejay Diagnostics, Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Soft Tissue Infections
Treatment
N/AClinical Study ID
NCT05665153
CES-0006_r2.1
Ages > 22 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Whole-blood specimen collected in EDTA anticoagulant tube
- Subject is 22+ years of age
- A minimum volume of 0.3 ml blood will be collected for Symphony IL-6 testing
- Subjects who have concurrently received CRP test results
- Subject is confirmed to be COVID-19 positive by an EUA or FDA cleared SARS-CoV-2positive RT-PCR test, and/or the subject is confirmed to be influenza-A or influenza-Bpositive by an FDA cleared test.
Exclusion
Exclusion Criteria:
- Subject is receiving an anti-IL-6 treatment
- Hemolyzed specimens
Study Design
Total Participants: 200
Study Start date:
November 22, 2022
Estimated Completion Date:
November 21, 2024
Connect with a study center
University of Michigan Medical Center
Ann Arbor, Michigan 48109
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.